Zymergen Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 732
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $300M
Latest Deal Amount
  • Investors
  • 48

Zymergen General Information

Description

Developer of molecular technology intended to discover and deliver novel products and materials. The company's platform integrates artificial intelligence algorithms and robotic genomic to search the microbial genome and identify paths that human scientists cannot discover, thereby enabling companies to discover impossible new materials, commercialize new products and improve the economics of existing bio-manufactured products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Materials
Primary Office
  • 5980 Horton Street
  • Suite 105
  • Emeryville, CA 94608
  • United States
+1 (415) 000-0000

Zymergen Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Zymergen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series D) 08-Sep-2020 $300M 00000 00.000 Completed Generating Revenue
7. Later Stage VC (Series C) 13-Dec-2018 00000 00000 00000 Completed Generating Revenue
6. Early Stage VC (Series B) 29-Nov-2017 000.00 00000 00000 Completed Generating Revenue
5. Early Stage VC (Series B) 07-Oct-2016 00000 00000 00000 Completed Generating Revenue
4. Early Stage VC (Series A) 04-Jun-2015 000.00 000.00 000.00 Completed Generating Revenue
3. Seed Round 01-May-2014 000 000 Completed Stealth
2. Seed Round 01-Jun-2013 $2M $2M Completed Stealth
1. Accelerator/Incubator Completed Stealth
To view Zymergen’s complete valuation and funding history, request access »

Zymergen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 26,158,833 $0.001000 $0.02 $0.25 $0.25 1x $0.25 9.5%
Series A 21,998,250 $0.001000 $0.13 $1.66 $1.66 1x $1.66 7.99%
To view Zymergen’s complete cap table history, request access »

Zymergen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of molecular technology intended to discover and deliver novel products and materials. The company's platform
Biotechnology
Emeryville, CA
732 As of 2020
00000
0.000 0000-00-00
00000000000 00000

00000

smod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerc
000000000000 000000000
Berkeley, CA
00 As of 0000
000.00
000000000 - 000.00

00000000

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugi
0000 000000000
Berkeley, CA
00 As of 0000
0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zymergen Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lygos Venture Capital-Backed Berkeley, CA 00 000.00 000000000 - 000.00
00000000 Venture Capital-Backed Berkeley, CA 00 0000 00000000000 0000
0000000 Corporation Roslin, United Kingdom 0 0000000000
000000 00000000 Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
000000 Venture Capital-Backed Seattle, WA 0 000.00 000000000 - 000.00
You’re viewing 5 of 10 competitors. Get the full list »

Zymergen Executive Team (16)

Name Title Board Seat Contact Info
Joshua Hoffman Co-Founder, Board Member & Chief Executive Officer
Richard Pieters President, Products
Aaron Kimball Chief Technology Officer
Mina Kim JD Chief Legal Officer
Jack Gold Chief Marketing Officer
You’re viewing 5 of 16 executive team members. Get the full list »

Zymergen Board Members (8)

Name Representing Role Since
Dipchand Nishar SoftBank Group Board Member 000 0000
Jay Flatley Self Board Member 000 0000
Jed Dean Ph.D Zymergen Co-Founder, Board Member & Vice President, Operations and Engineering 000 0000
Joshua Hoffman Zymergen Co-Founder, Board Member & Chief Executive Officer 000 0000
Matthew Ocko Data Collective Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Zymergen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zymergen Investors (48)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Baillie Gifford Asset Manager Minority 000 0000 000000 0
Baron Funds Asset Manager Minority 000 0000 000000 0
DCVC Bio Venture Capital Minority 000 0000 000000 0
Perceptive Advisors Hedge Fund Minority 000 0000 000000 0
SciFi VC Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 48 investors. Get the full list »

Zymergen Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 19-Mar-2020 000000000000000000 Other Commercial Products 000000 0000000
Radiant Genomics 08-Jan-2018 Merger/Acquisition Other Commercial Services 000000 0000000
To view Zymergen’s complete acquisitions history, request access »

Zymergen Subsidiaries (1)

Company Name Industry Location Founded
0000000 00000000 Other Commercial Services Emeryville, CA 0000
To view Zymergen’s complete subsidiaries history, request access »